Shanghai GenTech Co., Ltd., a Chinese solutions provider with expertise in flat panel display, LED, PV, fiber optics, and bio-pharmaceutics, has expanded its reach into the life sciences sector through the strategic acquisition of compatriot firm Konosai Biotechnology Co., Ltd. This move signifies GenTech’s commitment to deepening its presence in the biotechnology industry.
With the integration of Konosai’s consumables, such as fillers, culture media, liquid storage consumables, and membrane filtration, GenTech is poised to offer a comprehensive suite of solutions to the biopharmaceutical industry. This integration will complement GenTech’s existing business segments, including biopharmaceutical water, bioprocessing equipment and engineering, and pharmaceutical full life cycle consulting and verification services. Konosai, with its established expertise in the isolation and purification field, will continue to operate as a key player in its domain, bolstering GenTech’s capabilities in life sciences.- Flcube.com
